The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: The California Cancer Registry, 1999–2004
dc.contributor.author | Brown, Monica | en_US |
dc.contributor.author | Tsodikov, Alex | en_US |
dc.contributor.author | Bauer, Katrina R. | en_US |
dc.contributor.author | Parise, Carol A. | en_US |
dc.contributor.author | Caggiano, Vincent | en_US |
dc.date.accessioned | 2008-03-06T19:08:26Z | |
dc.date.available | 2009-03-04T14:20:46Z | en_US |
dc.date.issued | 2008-02-15 | en_US |
dc.identifier.citation | Brown, Monica; Tsodikov, Alex; Bauer, Katrina R.; Parise, Carol A.; Caggiano, Vincent (2008). "The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: The California Cancer Registry, 1999–2004 The ideas and opinions expressed herein are those of the author(s), and endorsement by the State of California, Department of Health Services, the National Cancer Institute, the Centers for Disease Control and Prevention or their contractors and subcontractors is not intended nor should be concluded. ." Cancer 112(4): 737-747. <http://hdl.handle.net/2027.42/58020> | en_US |
dc.identifier.issn | 0008-543X | en_US |
dc.identifier.issn | 1097-0142 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/58020 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18189290&dopt=citation | |
dc.description.abstract | BACKGROUND Breast cancers that are negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) (triple negative [TN]) have been associated with high-grade histology, aggressive clinical behavior, and poor survival. It has been determined that breast cancers that are negative for ER and PR but positive for HER2 (double negative [DN]) share features with TN breast cancers. In this report, the authors quantified the contribution of HER2 as well as demographic and tumor characteristics to the survival of women with TN tumors, DN tumors, and other breast cancers (OBC). METHODS In total, 61,309 women who were diagnosed with invasive breast cancer between 1999–2004 were identified in the California Cancer Registry. Demographic and tumor characteristics of women with TN tumors were compared with those from women with DN tumors and women with OBC. A compound proportional hazards regression analysis (PHPH) (a generalization of the Cox proportional hazards model) was used to model these characteristics. RESULTS Women with TN tumors were younger, African American, Hispanic, and of lower socioeconomic status (SES), whereas women with DN tumors were slightly older; African American, and Asian/Pacific Islander. Women with TN and DN tumors presented with larger, higher grade, and higher stage than women with OBC. Survival among women with TN tumors was poorer compared with that among women with OBC but was nearly the same as that of women with DN tumors. Results of the regression analysis indicated that disease stage, tumor grade, SES, and race/ethnicity were significant risk factors for survival. Negative ER and PR status was associated with an increased risk of death. There was a small but significant difference in both long-term and short-term survival patients who had TN tumors compared with patients who had DN tumors. CONCLUSIONS Patients with TN tumors shared many clinical, demographic, and tumor features and had survival that was very similar survival to that of patients with DN tumors, and survival for both groups contrasted greatly with survival for patients with OBC. Disease stage, tumor grade, SES, race/ethnicity, negative ER and PR status, rather than negative HER2 status, were risk factors for survival. Cancer 2008. © 2008 American Cancer Society. | en_US |
dc.format.extent | 213894 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Cancer Research, Oncology and Pathology | en_US |
dc.title | The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: The California Cancer Registry, 1999–2004 | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationother | Public Health Institute/Cancer Surveillance Program, Sacramento, California ; Fax: (916) 454-6523 ; Cancer Surveillance Program, 2800 L Street, Suite 440, Sacramento, CA 95818 | en_US |
dc.contributor.affiliationother | Public Health Institute/California Cancer Registry, Sacramento, California | en_US |
dc.contributor.affiliationother | Sutter Institute for Medical Research, Sacramento, California | en_US |
dc.contributor.affiliationother | Sutter Institute for Medical Research, Sacramento, California ; Sutter Cancer Center/Cancer Surveillance Program, Sacramento, California | en_US |
dc.identifier.pmid | 18189290 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/58020/1/23243_ftp.pdf | |
dc.identifier.doi | http://dx.doi.org/10.1002/cncr.23243 | en_US |
dc.identifier.source | Cancer | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.